Sheila Bheddah

2.3k total citations
13 papers, 728 citations indexed

About

Sheila Bheddah is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Sheila Bheddah has authored 13 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Sheila Bheddah's work include Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Peptidase Inhibition and Analysis (3 papers). Sheila Bheddah is often cited by papers focused on Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Peptidase Inhibition and Analysis (3 papers). Sheila Bheddah collaborates with scholars based in United States, France and Germany. Sheila Bheddah's co-authors include Rashmi Bansal, Susan Winkler, Hartmut Koeppen, Paul Polakis, Gretchen Frantz, Fiona Zhong, Patrick J. Dowd, Dorothy French, Kim Newton and David Dornan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Sheila Bheddah

12 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Bheddah United States 9 480 363 132 87 83 13 728
Limei Ju United Kingdom 12 1.1k 2.2× 528 1.5× 40 0.3× 98 1.1× 51 0.6× 15 1.2k
Cary Esselens Spain 10 444 0.9× 208 0.6× 63 0.5× 145 1.7× 150 1.8× 14 836
Kenichiro Matsuda Japan 9 435 0.9× 192 0.5× 61 0.5× 23 0.3× 53 0.6× 35 694
David Goldschneider France 17 601 1.3× 241 0.7× 45 0.3× 215 2.5× 137 1.7× 25 868
Amanda Linkous United States 14 525 1.1× 247 0.7× 45 0.3× 23 0.3× 85 1.0× 22 886
Jean‐Bernard Lazaro United States 16 701 1.5× 385 1.1× 25 0.2× 75 0.9× 125 1.5× 32 961
Momchil V. Kolev United States 7 431 0.9× 122 0.3× 32 0.2× 210 2.4× 123 1.5× 7 644
I. Kärkkäinen Finland 7 323 0.7× 153 0.4× 26 0.2× 94 1.1× 58 0.7× 7 582
Inmaculada López-Sánchez United States 17 672 1.4× 167 0.5× 47 0.4× 57 0.7× 206 2.5× 25 825
H. Carl Le United States 8 614 1.3× 310 0.9× 36 0.3× 23 0.3× 58 0.7× 10 824

Countries citing papers authored by Sheila Bheddah

Since Specialization
Citations

This map shows the geographic impact of Sheila Bheddah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Bheddah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Bheddah more than expected).

Fields of papers citing papers by Sheila Bheddah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Bheddah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Bheddah. The network helps show where Sheila Bheddah may publish in the future.

Co-authorship network of co-authors of Sheila Bheddah

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Bheddah. A scholar is included among the top collaborators of Sheila Bheddah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Bheddah. Sheila Bheddah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Tanaka, Kentaro, Kumiko Isse, Mitsuhiro Takenoyama, et al.. (2017). Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer. Lung Cancer. 115. 116–120. 87 indexed citations
3.
4.
Koshkin, Vadim S., Paul Elson, Cristina Magi‐Galluzzi, et al.. (2017). Prognostic value of DLL3 expression and clinicopathologic features in small cell bladder cancer (SCBC).. Journal of Clinical Oncology. 35(6_suppl). 382–382. 1 indexed citations
5.
Kavalerchik, Edward, Satwant Lally, Tae Hyung Han, et al.. (2017). An open-label study of rovalpituzumab tesirine in patients with DLL3-expressing advanced solid tumors.. Journal of Clinical Oncology. 35(15_suppl). TPS2597–TPS2597. 1 indexed citations
6.
Peng, Stanford L., Laura R. Saunders, Sheila Bheddah, et al.. (2016). Metastatic melanoma, glioblastoma and high-grade extrapulmonary neuroendocrine carcinomas (NECs) as novel indications for rovalpituzumab tesirine: A delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC).. Journal of Clinical Oncology. 34(15_suppl). 11611–11611. 2 indexed citations
7.
Anderson, Wade, Michael Boyd, Jorge Aguilar, et al.. (2015). Initiation and Characterization of Small Cell Lung Cancer Patient-Derived Xenografts from Ultrasound-Guided Transbronchial Needle Aspirates. PLoS ONE. 10(5). e0125255–e0125255. 28 indexed citations
8.
Diaz, Dolores, Krishna P. Allamneni, Jacqueline M. Tarrant, et al.. (2011). Phosphorous Dysregulation Induced by MEK Small Molecule Inhibitors in the Rat Involves Blockade of FGF-23 Signaling in the Kidney. Toxicological Sciences. 125(1). 187–195. 15 indexed citations
9.
Callow, Marinella, Hoanh Tran, Lilian Phu, et al.. (2011). Ubiquitin Ligase RNF146 Regulates Tankyrase and Axin to Promote Wnt Signaling. PLoS ONE. 6(7). e22595–e22595. 169 indexed citations
10.
Chen, Youjun, Suzanna Clark, Terence Z. Wong, et al.. (2007). Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models. Cancer Research. 67(10). 4924–4932. 70 indexed citations
11.
Jubb, Adrian M., Fiona Zhong, Sheila Bheddah, et al.. (2005). EphB2 is a Prognostic Factor in Colorectal Cancer. Clinical Cancer Research. 11(14). 5181–5187. 91 indexed citations
12.
Dornan, David, Sheila Bheddah, Kim Newton, et al.. (2004). COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas. Cancer Research. 64(20). 7226–7230. 110 indexed citations
13.
Bansal, Rashmi, Susan Winkler, & Sheila Bheddah. (1999). Negative Regulation of Oligodendrocyte Differentiation by Galactosphingolipids. Journal of Neuroscience. 19(18). 7913–7924. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Limei Ju Breakdown of academic impact, for papers by Cary Esselens Breakdown of academic impact, for papers by Kenichiro Matsuda Breakdown of academic impact, for papers by David Goldschneider Breakdown of academic impact, for papers by Amanda Linkous Breakdown of academic impact, for papers by Jean‐Bernard Lazaro Breakdown of academic impact, for papers by Momchil V. Kolev Breakdown of academic impact, for papers by I. Kärkkäinen Breakdown of academic impact, for papers by Inmaculada López-Sánchez Breakdown of academic impact, for papers by H. Carl Le
Rankless by CCL
2026